title: Octreotide and hepatocellular carcinoma.
authors.forename: F
authors.initials: F
authors.lastname: Farinati
authors.forename: A
authors.initials: A
authors.lastname: Sergio
authors.forename: A
authors.initials: A
authors.lastname: Baldan
authors.forename: P
authors.initials: P
authors.lastname: Zucchetta
authors.forename: V D
authors.initials: VD
authors.lastname: Corleto
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D015282:Octreotide / Q000009:adverse effects / Q000627:therapeutic use*; D017481:Receptors, Somatostatin / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017481:Receptors, Somatostatin; D015282:Octreotide